Human T-cell lymphotropic virus type 1-infected T lymphocytes impair catabolism and uptake of glutamate by astrocytes via Tax-1 and tumor necrosis factor alpha

Journal of Virology

Volumn 74, Issue 14, 2000, Pages 6433-6441

  Szymocha, Raphaël ^a   Akaoka, Hideo ^a   Dutuit, Magali ^a   Malcus, Christophe ^b   Didier Bazes, Marianne ^a   Belin, Marie Françoise ^a   Giraudon, Pascale ^a  

^a INSERM   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; TAX PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL METABOLISM; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD DISEASE; T LYMPHOCYTE; VIRUS PATHOGENESIS;

EID: 0033945533     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.14.6433-6441.2000     Document Type: Article

References (68)

1. Akaoka, H., H. Hardin-Pouzet, A. Bernard, B. Verrier, M. F. Belin, and P. Giraudon. 1996. Imbalanced expression of glutamate-glutamine cycle enzymes induced by human T-cell lymphotropic virus type 1 Tax protein in cultivated astrocytes. J. Virol. 70:8727-8736.
2. Barone, F. C., and G. Z. Feuerstein. 1999. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19:819-834.
3. Beimling, P., and K. Moelling. 1989. Isolation and characterization of the tax protein of HTLV-I. Oncogene 4:511-516.
4. Belin, M. F., M. Didier-Bazes, H. Akaoka, H. Hardin-Pouzet, A. Bernard, and P. Giraudon. 1997. Changes in astrocytic glutamate catabolism enzymes following neuronal degeneration or viral infection. Glia 21:154-161.
5. Beraud, C., G. Lombard-Platet, Y. Michal, and P. Jalinot. 1991. Binding of the HTLV-I Tax1 transactivator to the inducible 21 bp enhancer is mediated by the cellular factor HEB1. EMBO J. 10:3795-3803.
6. Billups, B., D. Rossi, T. Oshima, O. Warr, M. Takahashi, M. Sarantis, M. Szatkowski, and D. Attwell. 1998. Physiological and pathological operation of glutamate transporters. Prog. Brain Res. 116:45-57.
7. Bittigau, P., and C. Ikonomidou. 1997. Glutamate in neurologic diseases. J. Child. Neurol. 12:471-485.
8. Buckle, G. J., D. A. Hafler, and P. Hollsberg. 1996. HTLV-I-induced T-cell activation. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S107-S113.
9. Cartier, L. M., J. G. Cea, C. Vergara, F. Araya, and P. Born. 1997. Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system. J. Neuropathol. Exp. Neurol. 56:403-413.
10. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation hy acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
11. Cowan, E. P., R. K. Alexander, S. Daniel, F. Kashanchi, and J. N. Brady. 1997. Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax. J. Virol. 71:6982-6989.
12. Drejer, J., O. M. Larsson, and A. Schousboe. 1982. Characterization of L-glutamate uptake into and release from astrocytes and neurons cultured from different brain regions. Exp. Brain Res. 47:259-269.
13. Erecinska, M., and I. A. Silver. 1990. Metabolism and role of glutamate in mammalian brain. Prog. Neurobiol. 35:245-296.
14. Fine, S. M., R. A. Angel, S. W. Perry, L. G. Epstein, J. D. Rothstein, S. Dewhurst, and H. A. Gelbard. 1996. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J. Biol. Chem. 271:15303-15306.
15. Garlin, A. B., A. D. Sinor, J. D. Sinor, S. H. Jee, J. B. Grinspan, and M. B. Robinson. 1995. Pharmacology of sodium-dependent high-affinity L-[3H]glutamate transport in glial cultures. J. Neurochem. 64:2572-2580.
16. Gegelashvili, G., and A. Schousboe. 1997. High affinity glutamate transporters: regulation of expression and activity. Mol. Pharmacol. 52:6-15.
17. Gelbard, H. A., K. A. Dzenko, D. DiLoreto, C. del Cerro, M. del Cerro, and L. G. Epstein. 1993. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev. Neurosci. 15:417-422.
18. Gessain, A., F. Barin, J. C. Vernant, O. Gout, L. Maurs, A. Calender, and G. de The. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
19. Giraudon, P., A. Bernard, C. Malcus, N. Dufay, C. Desgranges, and M. F. Belin. 1995. Retroviral infection (HTLV-I) induces cytokine-regulated immunomodulation and cytotoxicity of medulloblastoma cells. J. Neuropathol. Exp. Neurol. 54:165-174.
20. Giraudon, P., S. Buart, A. Bernard, N. Thomasset, and M. F. Belin. 1996. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I). Prog. Neurobiol. 49:169-184.
21. Giraudon, P., N. Dufay, H. Hardin, A. Reboul, M. Tardy, and M. F. Belin. 1993. Differentiation of a medulloblastoma cell line towards an astrocytic lineage using the human T lymphotropic retrovirus-1. Neuroscience 52: 1069-1079.
22. Giraudon, P., N. Thomasset, A. Bernard, B. Verrier, and M. F. Belin. 1995. Induction of MMP9 (92 KDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I. Eur. J. Neurosci. 7:841-848.
23. Giraudon, P., J. C. Vernant, C. Confavreux, M. F. Belin, and C. Desgranges. 1998. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis. Neurology 50: 1920.
24. Hamprecht, B., and R. Dringen. 1995. Energy metabolism, p. 473-487. In H. Kettenmann and B. R. Ransom (ed.), Neuroglia. Oxford University Press, New York, N.Y.
25. Ijichi, S., S. Izumo, N. Eiraku, K. Machigashira, R. Kubota, M. Nagai, N. Ikegami, N. Kashio, F. Umehara, I. Maruyuma, et al. 1993. An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP. Med. Hypotheses 41:542-547.
26. Jeffery, K. J., K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, A. L. Lloyd, M. A. Nowak, M. Nagai, D. Kodama, S. Izumo, M. Osame, and C. R. Bangham. 1999. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 96:3848-3853.
27. Jennings, M. T., D. L. Jennings, S. A. Ebrahim, M. D. Johnson, C. Turc-Carel, T. Philip, I. Philip, C. Lapras, and J. R. Shapiro. 1992. In vitro karyotypic and immunophenotypic characterisation of primitive neuroectodermal tumours: similarities to malignant gliomas. Eur. J. Cancer 28A:762-766.
28. Kanai, Y. 1997. Family of neutral and acidic amino acid transporters: molecular biology, physiology and medical implications. Curr. Opin. Cell Biol. 9:565-572.
29. Kanai, Y., D. Trotti, S. Nussberger, and M. A. Hediger. 1997. The high affinity glutamate transporter family: structure, function and physiological relevance, p. 151-170. In M. E. A. Reith (ed.), Neurotransmitter transporters. Humana Press, Totowa, N.J.
30. Kimelberg, H. K., S. K. Goderie, P. A. Conley, S. Higman, R. Goldschmidt, and R. H. Amundson. 1992. Uptake of [3H]serotonin and [3H]glutamate by primary astrocyte cultures. I. Effects of different sera and time in culture. Glia 6:1-8.
31. Kinoshita, T., M. Shimoyama, K. Tobinai, M. Ito, S. Ito, S. Ikeda, K. Tajima, K. Shimotohno, and T. Sugimura. 1989. Detection of mRNA for the tax1/ rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:5620-5624.
32. Kohji, T., N. Tanuma, Y. Aikawa, Y. Kawazoe, Y. Suzuki, K. Kohyama, and Y. Matsumoto. 1998. Interaction between apoptotic cells and reactive brain cells in the central nervous system of rats with autoimmune encephalomyelitis. J. Neuroimmunol. 82:168-174.
33. Kubota, R., F. Umehara, S. Izumo, S. Ijichi, K. Matsumuro, S. Yashiki, T. Fujiyoshi, S. Sonoda, and M. Osame. 1994. HTLV-I proviral DNA amount correlates with infiltrating CD4+ lymphocytes in the spinal cord from patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 53:23-29.
34. Lehky, T. J., C. H. Fox, S. Koenig, M. C. Levin, N. Flerlage, S. Izumo, E. Sato, C. S. Raine, M. Osame, and S. Jacobson. 1995. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann. Neurol. 37:167-175.
35. Lindholm, P. F., R. L. Reid, and J. N. Brady. 1992. Extracellular Tax1 protein stimulates tumor necrosis factor beta and immunoglobulin kappa light chain expression in lymphoid cells. J. Virol. 66:1294-1302.
36. Mattson, D. H., D. E. McFarlin, C. Mora, and V. Zaninovic. 1987. Central-nervous-system lesions detected by magnetic resonance imaging in an HTLV-I antibody positive symptomless individual. Lancet ii:49.
37. McDonald, J. W., S. P. Althomsons, K. L. Hyrc, D. W. Choi, and M. P. Goldberg. 1998. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat. Med. 4:291-297.
38. McKay, R., P. Renfranz, and M. Cunningham. 1993. Immortalized stem cells from the central nervous system. C. R. Acad. Sci. Ser. III 316:1452-1457.
39. McKenna, M. C., J. T. Tildon, J. H. Stevenson, and X. Huang. 1996. New insights into the compartmentation of glutamate and glutamine in cultured rat brain astrocytes. Dev. Neurosci. 18:380-390.
40. + HTLV-1-specific cytotoxic T cells. J. Virol. 71:9143-9149.
41. Mohler, K. M., and L. D. Butler. 1991. Quantitation of cytokine mRNA levels utilizing the reverse transcriptase-polymerase chain reaction following primary antigen-specific sensitization in vivo. I. Verification of linearity, reproducibility and specificity. Mol. Immunol. 28:437-447.
42. Moritoyo, T., S. Izumo, H. Moritoyo, Y. Tanaka, Y. Kiyomatsu, M. Nagai, K. Usuku, M. Sorimachi, and M. Osame. 1999. Detection of human T-lymphotropic virus type 1 p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J. Neurovirol. 5:241-248.
43. Moritoyo, T., T. A. Reinhart, H. Moritoyo, E. Sato, S. Izumo, M. Osame, and A. T. Haase. 1996. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann. Neurol. 40:84-90.
44. Mulloy, J. C., T. Kislyakova, A. Cereseto, L. Casareto, A. LoMonico, J. Fullen, M. V. Lorenzi, A. Cara, C. Nicot, C. Giam, and G. Franchini. 1998. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72:8852-8860.
45. Munoz-Fernandez, M. A., and M. Fresno. 1998. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56:307-340.
46. Nagai, M., K. Usuku, W. Matsumoto, D. Kodama, N. Takenouchi, T. Moritoyo, S. Hashiguchi, M. Ichinose, C. R. Bangham, S. Izumo, and M. Osame. 1998. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J. Neurovirol. 4:586-593.
47. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitani, A. Igata, M. Matsumoto, and M. Tara. 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1:1031-1032.
48. Plaitakis, A., S. Berl, and M. D. Yahr. 1984. Neurological disorders associated with deficiency of glutamate dehydrogenase. Ann. Neurol. 15:144-153.
49. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
50. Popovic, M., G. Lange-Wantzin, P. S. Sarin, D. Mann, and R. C. Gallo. 1983. Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus. Proc. Natl. Acad. Sci. USA 80:5402-5406.
51. Robinson, M. B., and L. A. Dowd. 1997. Heterogeneity and functional properties of subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system. Adv. Pharmacol. 37:69-115.
52. Ruthstein, J. D., M. Dykes-Hoberg, C. A. Pardo, L. A. Bristol, L. Jin, R. W. Kuncl, Y. Kanai, M. A. Hediger, Y. Wang, J. P. Schielke, and D. F. Welty. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
53. Salahuddin, S. Z., P. D. Markham, F. Wong-Staal, G. Franchini, V. S. Kalyanaraman, and R. C. Gallo. 1983. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 129:51-64.
54. Schousboe, A., U. Sonnewald, G. Civenni, and G. Gegelashvili. 1997. Role of astrocytes in glutamate homeostasis. Implications for excitotoxicity. Adv. Exp. Med. Biol. 429:195-206.
55. Sibson, N. R., A. Dhankhar, G. F. Mason, D. L. Rothman, K. L. Behar, and R. G. Shulman. 1998. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc. Natl. Acad. Sci. USA 95:316-321.
56. Szymocha, R., et al. J. Neurovirol., in press.
57. Tendler, C., S. Greenberg, J. Burton, D. Danielpour, S. Kim, W. Blattner, A. Manns, and T. Waldmann. 1991. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell. Biochem. 46:302-311.
58. Umehara, F., S. Izumo, A. T. Ronquillo, K. Matsumuro, E. Sato, and M. Osame. 1994. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 53:72-77.
59. Umehara, F., S. Izumo, M. Takeya, K. Takahashi, E. Sato, and M. Osame. 1996. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP-1) in the spinal cord lesions in HTLV-I-associated myelopathy. Acta Neuropathol. (Berlin) 91:343-350.
60. Umehara, F., A. Nakamura, S. Izumo, R. Kubota, S. Ijichi, N. Kashio, K. Hashimoto, K. Usuku, E. Sato, and M. Osame. 1994. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-1-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J. Neuropathol. Exp. Neurol. 53:617-624.
61. Umehara, F., Y. Okada, N. Fujimoto, M. Abe, S. Izumo, and M. Osame. 1998. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 57:839-849.
62. Van Der Voorn, P., J. Tekstra, R. H. Beelen, C. P. Tensen, P. Van Der Valk, and C. J. De Groot. 1999. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 154:45-51.
63. Weiss, J. M., S. A. Downie, W. D. Lyman, and J. W. Berman. 1998. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J. Immunol. 161:6896-6903.
64. Wodarz, D., M. A. Nowak, and C. R. Bangham. 1999. The dynamics of HTLV-I and the CTL response. Immunol. Today 20:220-227.
65. Wong, D., R. Prameya, and K. Dorovini-Zis. 1999. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 58:138-152.
66. Wu, E., D. W. Dickson, S. Jacobson, and C. S. Raine. 1993. Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunulogic correlations. Acta Neuropathol. (Berlin) 86:224-235.
67. Yavin, E., and Z. Yavin. 1974. Attachment and culture of dissociated cells from rat embryo cerebral hemispheres on polylysine-coated surface. J. Cell Biol. 62:540-546.
68. Yu, N., J. N. Billaud, and T. R. Phillips. 1998. Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. Proc. Natl. Acad. Sci. USA 95: 2624-2629.